Corticosteroid Therapy in Pediatric Patients

General Dosing Guidelines

The American Academy of Pediatrics recommends starting with prednisolone 1-2 mg/kg/day (maximum 60 mg/day) as a single morning dose for most acute pediatric conditions requiring high-dose corticosteroid therapy 1, 2
The dose should be administered as a single daily dose in the morning to minimize adrenocortical suppression, as suggested by the Kidney International guidelines 2
For significantly overweight children, the dose should be calculated based on ideal body weight rather than actual weight to avoid excessive steroid exposure, according to the Praxis Medical Insights guidelines 1, 4

For asthma exacerbations, the American College of Allergy, Asthma, and Immunology recommends 1-2 mg/kg/day (maximum 60 mg/day) for 3-10 days 1
For nephrotic syndrome, the Kidney International guidelines suggest an initial dose of 60 mg/m²/day or 2 mg/kg/day (maximum 60 mg/day) as a single daily dose for 4-6 weeks, followed by an alternate-day phase 2, 5, 4
For autoimmune hepatitis, the American Association for the Study of Liver Diseases recommends an initial dose of 1-2 mg/kg/day (maximum 60 mg/day) for two weeks, either alone or with azathioprine 1, 4
For Duchenne muscular dystrophy, the Lancet Neurology guidelines suggest a standard daily dose of 0.75 mg/kg/day, with a minimum effective dose of 0.3 mg/kg/day 6

The American Academy of Pediatrics recommends reducing the dose by 5 mg every week until reaching 10 mg/day for courses longer than 10 days, then reducing by 2.5 mg/week until reaching maintenance dose 1

Regular assessment for steroid-related adverse effects, particularly with prolonged use, is recommended by the Praxis Medical Insights guidelines 1, 4
Growth monitoring in children on long-term therapy is also recommended by the Praxis Medical Insights guidelines 1, 4
Baseline and annual bone mineral density testing of lumbar spine and hip for long-term corticosteroid use is suggested by the Praxis Medical Insights guidelines 1

The American Academy of Pediatrics recommends avoiding systemic corticosteroids for bronchiolitis in infants under 2 years due to insufficient evidence of benefit 1
The Kidney International guidelines suggest considering corticosteroid-sparing agents for children with frequent relapses or steroid-dependent nephrotic syndrome who develop steroid-related adverse effects 2, 5, 4